Register to Access

Emerging role of biomarkers for cardiovascular risk assessment in T2DM and optimisation of cardioprotective treatment: current evidence and future trends

15 September 2022, from 18:00 to 19:00 CET Europe/Paris Emerging role of biomarkers for cardiovascular risk assessment in T2DM and optimisation of cardioprotective treatment: current evidence and future trends Access event page https://esc365.escardio.org/event/471 2022-09-15T18:00:00 2022-09-15T19:00:00
logo

Organiser: Heart Failure Association of the ESC (HFA)
Topic: Diagnostic Methods
Host: Professor P. Seferovic (Belgrade, RS)
Speakers: Professor A. Mebazaa (Paris, FR) , Doctor A. Bayes Genis (Badalona, ES)

Webinar

Registration

Free for everyone

Add to calendar Europe/Paris Emerging role of biomarkers for cardiovascular risk assessment in T2DM and optimisation of cardioprotective treatment: current evidence and future trends Access event page https://esc365.escardio.org/event/471 2022-09-15T18:00:00 2022-09-15T19:00:00

About the contributors

Professor Petar Seferovic

Belgrade University, Faculty of Medicine, Belgrade (Serbia)

Role: Host

Professor Alexandre Mebazaa

Hospital Lariboisiere, Paris (France)

Role: Speaker

Doctor Antonio Bayes Genis

University Hospital Germans Trias and Pujol de Badalona, Badalona (Spain)

Role: Speaker

This platform is supported by

logo Novo Nordisk